THE SUM OF TUMOR SIZE PREDICTS THE EFFICACY OF IMMUNE CHECKPOINT INHIBITORS IN NON-SMALL CELL LUNG CANCER

被引：0

作者：

Shiraishi, Yusuke ^{[1
]}

Marumo, Satoshi ^{[1
]}

Amimoto, Hisanori ^{[1
]}

Yamaki, Haruka ^{[1
]}

Shirata, Masahiro ^{[1
]}

Imoto, Takamitsu ^{[1
]}

Kitajima, Takamasa ^{[1
]}

Inoue, Daiki ^{[1
]}

Katayama, Yuko ^{[1
]}

Fukui, Motonari ^{[1
]}

机构：

[1] Kitano Hosp, Tazuke Kofukai Med Res Inst, Resp Dis Ctr, Osaka, Japan

来源：

RESPIROLOGY | 2018年 / 23卷

关键词：

D O I：

暂无

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

AP547

引用

页码：289 / 289

页数：1

共 50 条

[21] Chronological Effects of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer [J].

Guo, Xinyue ;

Qin, Lanqun ;

Wang, Xinmeng ;

Geng, Qian ;

Li, Dongqing ;

Lu, Yingying ;

Jiang, Hua .

IMMUNOLOGY, 2025, 174 (04) :402-410

[22] Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancer [J].

Lin, Gen ;

Wang, Zhijie ;

Chu, Qian ;

Hu, Yi ;

Huang, Dingzhi ;

Wang, Jun ;

Yang, Fan ;

Zhong, Wenzhao ;

Zhou, Chengzhi ;

Zhu, Bo ;

Ai, Xinghao ;

Cao, Baoshan ;

Cao, Yabing ;

Chen, Mingqiu ;

Chen, Xiaohui ;

Chu, Tianqing ;

Duan, Jianchun ;

Fan, Yun ;

Fang, Yong ;

Feng, Shuitu ;

Feng, Weineng ;

Guo, Hui ;

Han, Chengbo ;

He, Yong ;

Hong, Shaodong ;

Hu, Jie ;

Huang, Meijuan ;

Huang, Yan ;

Jiang, Da ;

Jiang, Kan ;

Jiang, Richeng ;

Jin, Bo ;

Jin, Shi ;

Li, Jisheng ;

Li, Min ;

Li, Ziming ;

Li, Chao ;

Lin, Jie ;

Liu, Anwen ;

Liu, Si-Yang Maggie ;

Yutao, Liu ;

Liu, Zhefeng ;

Liu, Zhe ;

Liu, Zhenhua ;

Liu, Zhentian ;

Liu, Zhigang ;

Lu, Yuping ;

Lv, Tangfeng ;

Ma, Zhiyong ;

Miao, Qian .

THORACIC CANCER, 2024, 15 (05) :419-426

[23] The role of immune checkpoint inhibitors in advanced non-small cell lung cancer [J].

Pistamaltzian, Nikolaos F. ;

Georgoulias, Vassilis ;

Kotsakis, Athanasios .

EXPERT REVIEW OF RESPIRATORY MEDICINE, 2019, 13 (05) :435-447

[24] Immune checkpoint inhibitors and driver oncogenes in non-small cell lung cancer [J].

Miura, Yosuke ;

Kasahara, Norimitsu ;

Sunaga, Noriaki .

TRANSLATIONAL CANCER RESEARCH, 2019, 8 :S628-S632

[25] Safety of current immune checkpoint inhibitors in non-small cell lung cancer [J].

Abdayem, Pamela ;

Planchard, David .

EXPERT OPINION ON DRUG SAFETY, 2021, 20 (06) :651-667

[26] Achievements and futures of immune checkpoint inhibitors in non-small cell lung cancer [J].

Zhenbin Qiu ;

Zihao Chen ;

Chao Zhang ;

Wenzhao Zhong .

Experimental Hematology & Oncology, 8

[27] Immune checkpoint inhibitors in therapy of non-small cell lung cancer (a review) [J].

Kolesnik, O. P. ;

Mykhailychenko, V. V. .

ZAPOROZHYE MEDICAL JOURNAL, 2021, 23 (03) :418-425

[28] The progresses of relevant factors on the efficacy of immune checkpoint inhibitors in the non-small cell lung cancer patients [J].

Yu, Zhaoqing ;

Qin, Li ;

Yu, Guifang .

CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2023, 37

[29] Explore the efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients of different gender [J].

Zheng, S-Y. ;

Cui, H-J. .

ANNALS OF ONCOLOGY, 2020, 31 :S715-S715

[30] Efficacy and safety of immune checkpoint inhibitors in previously treated metastatic non-small cell lung cancer [J].

Cunha, R. ;

Fernandes, M. ;

Abreu, S. ;

Oliveira, C. ;

Dias, J. ;

Alves, S. ;

Rodrigues, A. ;

Oliveira, J. ;

Pousa, M. I. ;

Soares, M. ;

Azevedo, I. .

ANNALS OF ONCOLOGY, 2020, 31 :S1432-S1432

← 1 2 3 4 5 →